News | December 27, 2024
Mankind Pharma and Innovent Biologics join forces for cancer care with Sintilimab
Mankind Pharma will have exclusive rights to register, import, market, sell and distribute sintilimab in India
Mankind Pharma will have exclusive rights to register, import, market, sell and distribute sintilimab in India
In the US, the compassionate use approvals are provided by FDA in the form of individual patient-specific expanded-access IND
Partnership to supercharge LVMH Recherche with Integrated Biosciences’ innovative AI and synthetic biology platform for targeting skin aging
Aims to become India’s leading cancer testing company
GSK secures option to multiple high-value, validated Alzheimer’s-relevant targets for drug discovery, development, and commercialization
Designation was based on early efficacy data demonstrating an 83.3% (10/12) overall response rate and a 50% (6/12) complete response rate, with a well-managed safety profile in Relapsed/Refractory Hodgkin Lymphoma patients
Despite NTC014, due to its simplified therapeutic regimen, has been administered at a lower posology than the antibiotic comparator
In the near term, the company targets a 42% reduction in absolute Scope 1 and 2 emissions and Scope 3 emissions by FY2030
New research labs and process development services to enable next generation therapeutics
HYMPAVZI’s approval is based on Phase 3 study results demonstrating non-inferiority and superiority compared to routine prophylaxis in eligible patients with hemophilia A or B without inhibitors
Subscribe To Our Newsletter & Stay Updated
